Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Antituberculous Treatment Itself Might Prevent Visual Impairment in Presumed Tuberculosis-Related Uveitis.

Llorenç V, Benejam G, Mesquida M, Sainz de la Maza M, Molins B, Alba C, Pelegrin L, Martínez JA, Adán A.

Ocul Immunol Inflamm. 2018 Nov 5:1-8. doi: 10.1080/09273948.2018.1541326. [Epub ahead of print]

PMID:
30395738
2.

Botulinum toxin for treating unilateral apraxia of eyelid opening in a patient with congenital myotonia.

Fernández E, Latasiewicz M, Pelegrin L, Romera M, Schellini S, Galindo-Ferreiro A.

Arq Bras Oftalmol. 2017 Sep-Oct;80(5):330-331. doi: 10.5935/0004-2749.20170081.

3.

Characterization of isolated retinal vasculitis. Analysis of a cohort from a single center and literature review.

Pelegrín L, Hernández-Rodríguez J, Espinosa G, Llorenç V, Sainz-de-la-Maza M, Fontenla JR, Martínez JA, Cid MC, Adán A.

Autoimmun Rev. 2017 Mar;16(3):237-243. doi: 10.1016/j.autrev.2017.01.006. Epub 2017 Jan 27. Review.

PMID:
28137481
4.

Development of an activity disease score in patients with uveitis (UVEDAI).

Pato E, Martin-Martinez MA, Castelló A, Méndez-Fernandez R, Muñoz-Fernández S, Cordero-Coma M, Martinez-Costa L, Valls E, Reyes M, Francisco F, Esteban M, Fonollosa A, Sanchez-Alonso F, Fernández-Espartero C, Diaz-Valle T, Carrasco JM, Beltran-Catalán E, Hernández-Garfella M, Hernández MV, Pelegrin L, Blanco R, Diaz-Valle D.

Rheumatol Int. 2017 Apr;37(4):647-656. doi: 10.1007/s00296-016-3593-1. Epub 2016 Nov 4.

5.

Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.

Pelegrín L, de la Maza MS, Molins B, Ríos J, Adán A.

Eye (Lond). 2015 Jul;29(7):943-50. doi: 10.1038/eye.2015.73. Epub 2015 May 22.

6.

Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment.

Molins B, Mesquida M, Lee RW, Llorenç V, Pelegrín L, Adán A.

Clin Exp Immunol. 2015 Mar;179(3):529-38. doi: 10.1111/cei.12479.

7.

An old disease in an atypical place.

Pelegrín L, Adán A, López-Guillermo A, Martinez A, Shields CL.

Surv Ophthalmol. 2014 Nov-Dec;59(6):660-3. doi: 10.1016/j.survophthal.2014.01.011. Epub 2014 May 28.

PMID:
25233826
8.

Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency.

Zarranz-Ventura J, Carreño E, Johnston RL, Mohammed Q, Ross AH, Barker C, Fonollosa A, Artaraz J, Pelegrin L, Adan A, Lee RW, Dick AD, Sallam A.

Am J Ophthalmol. 2014 Dec;158(6):1136-1145.e5. doi: 10.1016/j.ajo.2014.09.003. Epub 2014 Sep 8.

PMID:
25217856
9.

[Retinal vasculopathy in systemic lupus erythematosus: a case of lupus vasculitis and a case of non-vasculitis venous occlusion].

Figueras-Roca M, Rey A, Mesquida M, Pelegrín L, Llorens V, Fontenla JR, Adán A.

Arch Soc Esp Oftalmol. 2014 Feb;89(2):66-9. doi: 10.1016/j.oftal.2012.06.030. Epub 2012 Oct 8. Spanish.

PMID:
24269411
10.

Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement.

Pelegrin L, Jakob E, Schmidt-Bacher A, Schwenger V, Becker M, Max R, Lorenz HM, Mackensen F.

J Rheumatol. 2014 Jan;41(1):84-90. doi: 10.3899/jrheum.130206. Epub 2013 Nov 15.

PMID:
24241484
11.

Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis.

Pelegrín L, Casaroli-Marano R, Antón J, García de Vicuña MC, Molina-Prat N, Ignacio Aróstegui J, Yagüe J, Ríos J, Adán A.

Ocul Immunol Inflamm. 2014 Jun;22(3):208-12. doi: 10.3109/09273948.2013.841495. Epub 2013 Oct 16.

PMID:
24131380
12.

Tocilizumab treatment for refractory uveitis-related cystoid macular edema.

Adán A, Mesquida M, Llorenç V, Espinosa G, Molins B, Hernández MV, Pelegrín L.

Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2627-32. doi: 10.1007/s00417-013-2436-y. Epub 2013 Jul 27.

PMID:
23893042
13.

Cytokine profiling reveals decreased serum levels of CCL2 in active ocular toxoplasmosis.

Rey A, Molins B, Llorenç V, Pelegrín L, Mesquida M, Adán A.

Br J Ophthalmol. 2013 Oct;97(10):1338-42. doi: 10.1136/bjophthalmol-2013-303092. Epub 2013 Jul 22.

PMID:
23878135
14.

Late spectral-domain optical coherence tomography findings in sub-internal limiting membrane hemorrhage.

Rey A, Adán A, Llorenç V, Pelegrín L, Mesquida M.

Retin Cases Brief Rep. 2013 Summer;7(3):276-7. doi: 10.1097/ICB.0b013e31828eefbd.

PMID:
25391123
15.

Clinical pattern of toxoplasmic retinochoroiditis in a Spanish referral center.

Rey A, Llorenç V, Pelegrín L, Mesquida M, Molins B, Rios J, Arévalo JF, Adán A.

Ophthalmologica. 2013;229(3):173-8. doi: 10.1159/000348740. Epub 2013 Mar 27.

PMID:
23548496
16.

Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.

Adán A, Pelegrín L, Rey A, Llorenç V, Mesquida M, Molins B, Ríos J, Keller J.

Retina. 2013 Jul-Aug;33(7):1435-40. doi: 10.1097/IAE.0b013e31827e247b.

PMID:
23514796
17.

Tocilizumab treatment for recalcitrant uveitic macular edema.

Adán A, Llorenç V, Mesquida M, Pelegrín L.

Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2249-50. doi: 10.1007/s00417-012-2243-x. Epub 2012 Dec 28. No abstract available.

PMID:
23271335
18.

Behçet disease-associated uveitis successfully treated with golimumab.

Mesquida M, Victoria Hernández M, Llorenç V, Pelegrín L, Espinosa G, Dick AD, Adán A.

Ocul Immunol Inflamm. 2013 Apr;21(2):160-2. doi: 10.3109/09273948.2012.741744. Epub 2012 Dec 19.

PMID:
23252659
19.

Pars plana vitrectomy for vitreoretinal complications of Behçet uveitis.

Mesquida M, Pelegrín L, Llorenç V, Espinosa G, Ríos J, Dick AD, Adán A.

Eur J Ophthalmol. 2013 Jan 21;23(1):119 - 128. doi: 10.5301/ejo.5000194. Epub 2012 Sep 26.

PMID:
23065857
20.

Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays.

Llorenç V, González-Martin J, Keller J, Rey A, Pelegrín L, Mesquida M, Adán A.

Acta Ophthalmol. 2013 Mar;91(2):e99-e107. doi: 10.1111/j.1755-3768.2012.02564.x. Epub 2012 Oct 8.

Supplemental Content

Loading ...
Support Center